Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 71335-2085

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 71335-2085). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zolpidem Tartrate (B0207b5f 53fa 4b2c 8608 4095874aff98 01)

Zolpidem Tartrate (B0207b5f 53fa 4b2c 8608 4095874aff98 01)
Chemical structure of Zolpidem Tartrate, illustrating the molecular composition of the active ingredient in Zolpidem Tartrate extended release tablets.*
FDA Label Image

Im-2 (B0207b5f 53fa 4b2c 8608 4095874aff98 02)

Im-2 (B0207b5f 53fa 4b2c 8608 4095874aff98 02)
A line graph showing zolpidem plasma concentrations (ng/mL) over time (hours) comparing 12.5 mg zolpidem tartrate extended-release tablets and 10 mg zolpidem tartrate immediate-release tablets. The graph illustrates the concentration-time profiles for both formulations over an 8-hour period.*
FDA Label Image

Label (Lbl713352085)

Label (Lbl713352085)
Label for Zolpidem Tartrate ER 6.25 mg extended release tablets, packaged by Bryant Ranch Prepack in Burbank, CA. The label indicates the product is a Schedule IV controlled substance, compares to Ambien CR 6.25 mg tablets by Lupin Limited, and is provided in a quantity of 28 tablets. Storage instructions specify room temperature 20°-25°C (68°-77°F). Includes a barcode and NDC 71335-2085-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.